SFY 2018 - 2019 MC BHET Report Summary
HIV SNP line of business
- Document also available in Portable Document Format (PDF)
| Plan | BHET % | BHET Target Expense | BHET Experience | Remittance | MMs | |
|---|---|---|---|---|---|---|
| Amida Care Inc. | 121.98% | $15,731,995 | $19,190,529 | $0 | 74,228 | |
| MetroPlus Health Plan, Inc | 67.87% | $8,899,084 | $6,039,732 | $2,503,388 | 42,292 | |
| VNS (d/b/a VNSNY Choice) and Subsidiary | 67.91% | $8,160,483 | $5,541,620 | $2,292,443 | 37,537 | |
| Total | $32,791,562 | $30,771,881 | $4,795,831 | 154,057 |
NOTES:
BHET Target 96%
